TheStreet's Jim Cramer told "Mad Money" viewers what he'd be watching this week during his "Game Plan" segment on Friday. One of the events he has his eye on includes earnings from Monsanto (MON , due out Wednesday before the open.
For those unaware, Monsanto is being purchased by Bayer for $66 billion. Like other large M&A deals, there have been bumps in the road. But it's these bumps that are being watched by Cramer, the manager of the Action Alerts PLUS portfolio.
Since Monsanto is likely being acquired, the earnings aren't really the focus. Investors will want to see progress in an update on the Bayer deal, Cramer reasoned.
Investors who are long Dow should stay long, because the union with DuPont will turn the combined company into a powerhouse, Cramer suggested.
Earlier this week, Cramer praised DuPont's move to sell its crop-protection business to FMC Corp. (FMC - Get Report) in exchange for the latter's health and nutrition business and $1.2 billion in cash. It's a win-win for both companies, he concluded.
Watch more of Jim Cramer's latest videos on TheStreet:
- Jim Cramer on What's Next for Nvidia Shares
- Jim Cramer on Ralph Lauren Shutting its Iconic 5th Avenue Store
- Jim Cramer: I Want Walgreens-Rite Aid Deal to Come Together or Fall Apart Soon
- Jim Cramer on Trump's Meeting With CEOs: Focus on Tax Reform, Deregulation
- Jim Cramer Is Watching Bed Bath & Beyond's Earnings on Wednesday
- Jim Cramer: These Two Factors Should Help Caterpillar